Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
2.

Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.

Mottl AK, Buse JB, Ismail-Beigi F, Sigal RJ, Pedley CF, Papademetriou V, Simmons DL, Katz L, Mychaleckyj JC, Craven TE.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1693-1702. doi: 10.2215/CJN.06200518. Epub 2018 Oct 25.

PMID:
30361335
3.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
4.

Effect of Intensive Glycemic Control on Risk of Lower Extremity Amputation.

Goldman MP, Clark CJ, Craven TE, Davis RP, Williams TK, Velazquez-Ramirez G, Hurie JB, Edwards MS.

J Am Coll Surg. 2018 Dec;227(6):596-604. doi: 10.1016/j.jamcollsurg.2018.09.021. Epub 2018 Oct 16.

PMID:
30336205
5.

Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia.

Reeve TE 4th, Ur R, Craven TE, Kaan JH, Goldman MP, Edwards MS, Hurie JB, Velazquez-Ramirez G, Corriere MA.

J Vasc Surg. 2018 May;67(5):1512-1520. doi: 10.1016/j.jvs.2017.08.078. Epub 2017 Dec 21.

PMID:
29276105
6.

Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort.

Dungan K, Craven TE, Soe K, Wright JT Jr, Basile J, Haley WE, Kressin NR, Rani U, Tamariz L, Whittle J, Wiggers A, Osei K.

Diabetes Obes Metab. 2018 Mar;20(3):629-637. doi: 10.1111/dom.13127. Epub 2017 Nov 9.

7.

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.

Still CH, Rodriguez CJ, Wright JT Jr, Craven TE, Bress AP, Chertow GM, Whelton PK, Whittle JC, Freedman BI, Johnson KC, Foy CG, He J, Kostis JB, Lash JP, Pedley CF, Pisoni R, Powell JR, Wall BM; SPRINT Writing Group.

Am J Hypertens. 2017 Dec 8;31(1):97-107. doi: 10.1093/ajh/hpx138.

8.

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK; SPRINT Research Group.

Ann Intern Med. 2017 Sep 19;167(6):375-383. doi: 10.7326/M16-2966. Epub 2017 Sep 5.

PMID:
28869987
9.

The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).

Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S; SPRINT Study Research Group.

J Clin Hypertens (Greenwich). 2017 Nov;19(11):1152-1161. doi: 10.1111/jch.13062. Epub 2017 Sep 3.

10.

Effects of Intensive BP Control in CKD.

Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J; SPRINT Research Group.

J Am Soc Nephrol. 2017 Sep;28(9):2812-2823. doi: 10.1681/ASN.2017020148. Epub 2017 Jun 22.

11.

Superior Lower Extremity Vein Graft Bypass Patency among Married Patients with Peripheral Artery Disease.

Lagergren E, Kempe K, Craven TE, Kornegay ST, Hurie JB, Garg N, Velazquez-Ramirez G, Edwards MS, Corriere MA.

Ann Vasc Surg. 2017 Oct;44:48-53. doi: 10.1016/j.avsg.2017.01.026. Epub 2017 May 4.

PMID:
28479461
12.

Gender-specific Differences in Great Saphenous Vein Conduit. A Link to Lower Extremity Bypass Outcomes Disparities?

Lagergren ER, Kempe K, Craven TE, Kornegay ST, Garg N, Velazquez-Ramirez G, Hurie JB, Edwards MS, Corriere MA.

Ann Vasc Surg. 2017 Jan;38:36-41. doi: 10.1016/j.avsg.2016.09.003. Epub 2016 Sep 22.

PMID:
27666796
13.

Endovascular Treatment of Chronic Mesenteric Ischemia in the Setting of Occlusive Superior Mesenteric Artery Lesions.

Goldman MP, Reeve TE, Craven TE, Edwards MS, Corriere MA, Hurie JB, Garg N, Velazquez-Ramirez G.

Ann Vasc Surg. 2017 Jan;38:29-35. doi: 10.1016/j.avsg.2016.08.009. Epub 2016 Aug 28.

PMID:
27581131
14.

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Still CH, Craven TE, Freedman BI, Van Buren PN, Sink KM, Killeen AA, Bates JT, Bee A, Contreras G, Oparil S, Pedley CM, Wall BM, White S, Woods DM, Rodriguez CJ, Wright JT Jr; SPRINT Study Research Group.

J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7.

15.

Increased prevalence of preeclampsia among women undergoing procedural intervention for renal artery fibromuscular dysplasia.

Vance CJ, Taylor RN, Craven TE, Edwards MS, Corriere MA.

Ann Vasc Surg. 2015 Aug;29(6):1105-10. doi: 10.1016/j.avsg.2015.03.037. Epub 2015 May 22.

PMID:
26004957
16.

Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial.

Isakova T, Craven TE, Scialla JJ, Nickolas TL, Schnall A, Barzilay J, Schwartz AV; Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.

Bone. 2015 Sep;78:23-7. doi: 10.1016/j.bone.2015.04.037. Epub 2015 Apr 30.

17.

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):29-38. doi: 10.2215/CJN.06190614. Epub 2014 Oct 24.

18.

Influence of computed tomography angiography reconstruction software on anatomic measurements and endograft component selection for endovascular abdominal aortic aneurysm repair.

Corriere MA, Islam A, Craven TE, Conlee TD, Hurie JB, Edwards MS.

J Vasc Surg. 2014 May;59(5):1224-31.e1-3. doi: 10.1016/j.jvs.2013.11.003. Epub 2014 Jan 16.

19.

Stent effects on duplex velocity estimates.

Kuppler CS, Christie JW, Newton WB 3rd, Ghanami RJ, Craven TE, Berry JL, Hansen KJ.

J Surg Res. 2013 Jul;183(1):457-61. doi: 10.1016/j.jss.2012.03.004. Epub 2012 Mar 28.

PMID:
23601663
20.

Early duplex predicts restenosis after renal artery angioplasty and stenting.

Christie JW, Conlee TD, Craven TE, Hurie JB, Godshall CJ, Edwards MS, Hansen KJ.

J Vasc Surg. 2012 Nov;56(5):1373-80; discussion 1380. doi: 10.1016/j.jvs.2012.05.067.

21.

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Bonds DE, Craven TE, Buse J, Crouse JR, Cuddihy R, Elam M, Ginsberg HN, Kirchner K, Marcovina S, Mychaleckyj JC, O'Connor PJ, Sperl-Hillen JA.

Diabetologia. 2012 Jun;55(6):1641-50. doi: 10.1007/s00125-012-2524-2. Epub 2012 Mar 27.

22.

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

Ismail-Beigi F, Craven TE, O'Connor PJ, Karl D, Calles-Escandon J, Hramiak I, Genuth S, Cushman WC, Gerstein HC, Probstfield JL, Katz L, Schubart U; ACCORD Study Group.

Kidney Int. 2012 Mar;81(6):586-94. doi: 10.1038/ki.2011.415. Epub 2011 Dec 14.

23.

Diastolic function predicts survival after renal revascularization.

Ghanami RJ, Rana H, Craven TE, Hoyle J, Edwards MS, Hansen KJ.

J Vasc Surg. 2011 Dec;54(6):1720-6; discussion 1726. doi: 10.1016/j.jvs.2011.05.091. Epub 2011 Aug 6.

24.

Accuracy of duplex sonography scans after renal artery stenting.

Fleming SH, Davis RP, Craven TE, Deonanan JK, Godshall CJ, Hansen KJ.

J Vasc Surg. 2010 Oct;52(4):953-7; discussion 958. doi: 10.1016/j.jvs.2010.04.055.

25.

Trends in vena caval interruption.

Moore PS, Andrews JS, Craven TE, Davis RP, Corriere MA, Godshall CJ, Edwards MS, Hansen KJ.

J Vasc Surg. 2010 Jul;52(1):118-125.e3; discussion 125-6. doi: 10.1016/j.jvs.2009.09.067. Epub 2010 Mar 20.

26.

Associations between renal duplex parameters and adverse cardiovascular events in the elderly: a prospective cohort study.

Pearce JD, Craven TE, Edwards MS, Corriere MA, Crutchley TA, Fleming SH, Hansen KJ.

Am J Kidney Dis. 2010 Feb;55(2):281-90. doi: 10.1053/j.ajkd.2009.10.044.

27.

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, Childress RD, Craven TE, Cuddihy RM, Dailey G, Feinglos MN, Ismail-Beigi F, Largay JF, O'Connor PJ, Paul T, Savage PJ, Schubart UK, Sood A, Genuth S; ACCORD Investigators.

BMJ. 2010 Jan 8;340:b5444. doi: 10.1136/bmj.b5444.

28.

Atherosclerotic renovascular disease among hypertensive adults.

Davis RP, Pearce JD, Craven TE, Moore PS, Edwards MS, Godshall CJ, Hansen KJ.

J Vasc Surg. 2009 Sep;50(3):564-570, 571.e1-3; discussion 571. doi: 10.1016/j.jvs.2009.03.062.

29.

Changes in left ventricular structure and function following renal artery revascularization.

Corriere MA, Hoyle JR, Craven TE, D'Agostino RB Jr, Edwards MS, Moore PS, Hansen KJ.

Ann Vasc Surg. 2010 Jan;24(1):80-4. doi: 10.1016/j.avsg.2009.05.004. Epub 2009 Jul 23.

PMID:
19631505
30.

Clinical utility of the resistive index in atherosclerotic renovascular disease.

Crutchley TA, Pearce JD, Craven TE, Stafford JM, Edwards MS, Hansen KJ.

J Vasc Surg. 2009 Jan;49(1):148-55, 155.e1-3; discussion 155. doi: 10.1016/j.jvs.2008.08.008. Epub 2008 Oct 31.

31.

Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis.

Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin M, Margolis KL.

J Am Diet Assoc. 2008 Jan;108(1):91-100. Review.

PMID:
18155993
32.

Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study".

Chambers MS, Fleming TJ, Toth BB, Lemon JC, Craven TE, Bouwsma OJ, Garden AS, Espeland MA, Keene HJ, Martin JW, Sipos T.

Oral Oncol. 2007 Jan;43(1):98-105.

PMID:
18027401
33.

Branch renal artery repair with cold perfusion protection.

Crutchley TA, Pearce JD, Craven TE, Edwards MS, Dean RH, Hansen KJ.

J Vasc Surg. 2007 Sep;46(3):405-412; discussion 412. Epub 2007 Jul 30.

34.

Atheroembolism during percutaneous renal artery revascularization.

Edwards MS, Corriere MA, Craven TE, Pan XM, Rapp JH, Pearce JD, Mertaugh NB, Hansen KJ.

J Vasc Surg. 2007 Jul;46(1):55-61.

35.

Clinical course of mesenteric artery stenosis in elderly americans.

Wilson DB, Mostafavi K, Craven TE, Ayerdi J, Edwards MS, Hansen KJ.

Arch Intern Med. 2006 Oct 23;166(19):2095-100.

PMID:
17060539
36.

Progression of atherosclerotic renovascular disease: A prospective population-based study.

Pearce JD, Craven BL, Craven TE, Piercy KT, Stafford JM, Edwards MS, Hansen KJ.

J Vasc Surg. 2006 Nov;44(5):955-62; discussion 962-3. Epub 2006 Sep 18.

37.

Distal embolic protection during renal artery angioplasty and stenting.

Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J, Geary RL, Hansen KJ.

J Vasc Surg. 2006 Jul;44(1):128-35.

38.

Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study.

Edwards MS, Wilson DB, Craven TE, Stafford J, Fried LF, Wong TY, Klein R, Burke GL, Hansen KJ.

Am J Kidney Dis. 2005 Aug;46(2):214-24.

PMID:
16112039
39.

Renovascular disease in children and adolescents.

Piercy KT, Hundley JC, Stafford JM, Craven TE, Nagaraj SK, Dean RH, Hansen KJ.

J Vasc Surg. 2005 Jun;41(6):973-82.

40.

Renal duplex parameters, blood pressure, and renal function in elderly people.

Pearce JD, Edwards MS, Craven TE, English WP, Mondi MM, Reavis SW, Hansen KJ.

Am J Kidney Dis. 2005 May;45(5):842-50.

PMID:
15861349
41.

Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study.

Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ.

Arch Intern Med. 2005 Jan 24;165(2):207-13.

PMID:
15668368
42.

Chronic visceral ischemia: symptom-free survival after open surgical repair.

English WP, Pearce JD, Craven TE, Edwards MS, Geary RL, Plonk GW, Hansen KJ.

Vasc Endovascular Surg. 2004 Nov-Dec;38(6):493-503.

PMID:
15592629
43.

Surgical management of renal artery aneurysms.

English WP, Pearce JD, Craven TE, Wilson DB, Edwards MS, Ayerdi J, Geary RL, Dean RH, Hansen KJ.

J Vasc Surg. 2004 Jul;40(1):53-60.

44.

Mesenteric artery disease in the elderly.

Hansen KJ, Wilson DB, Craven TE, Pearce JD, English WP, Edwards MS, Ayerdi J, Burke GL.

J Vasc Surg. 2004 Jul;40(1):45-52.

45.

Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study.

Edwards MS, Hansen KJ, Craven TE, Bleyer AJ, Burke GL, Levy PJ, Dean RH.

Vasc Endovascular Surg. 2004 Jan-Feb;38(1):25-35.

PMID:
14760474
46.

Relationships between renovascular disease, blood pressure, and renal function in the elderly: a population-based study.

Edwards MS, Hansen KJ, Craven TE, Cherr GS, Bleyer AJ, Burke GL, Dean RH.

Am J Kidney Dis. 2003 May;41(5):990-6.

PMID:
12722033
47.

Acute occlusive mesenteric ischemia: surgical management and outcomes.

Edwards MS, Cherr GS, Craven TE, Olsen AW, Plonk GW, Geary RL, Ligush JL, Hansen KJ.

Ann Vasc Surg. 2003 Jan;17(1):72-9. Epub 2003 Jan 15.

PMID:
12522695
48.

Prevalence of renovascular disease in the elderly: a population-based study.

Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH.

J Vasc Surg. 2002 Sep;36(3):443-51.

PMID:
12218965
49.

Declines in strength and balance in older adults with chronic knee pain: a 30-month longitudinal, observational study.

Messier SP, Glasser JL, Ettinger WH Jr, Craven TE, Miller ME.

Arthritis Rheum. 2002 Apr 15;47(2):141-8.

50.

Surgical management of atherosclerotic renovascular disease.

Cherr GS, Hansen KJ, Craven TE, Edwards MS, Ligush J Jr, Levy PJ, Freedman BI, Dean RH.

J Vasc Surg. 2002 Feb;35(2):236-45.

Supplemental Content

Loading ...
Support Center